AGING

• Alzheimer's disease, Parkinson's disease and atherosclerosis.
  (Altamura S, et al. J Alzheimers Dis. 2009 Apr;16(4):879-95.)
  View Abstract
• Alzheimer's disease and atherosclerosis: Passers-by or brothers?
  (Xing Y, et al. Med Hypotheses. 2009 Apr 22. [Epub ahead of print])
  View Abstract
• Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease.
  (Noto N, et al. Pediatr Cardiol. 2009 Apr;30(3):262-8. Epub 2008 Nov 20.)
  View Abstract

APO / LIPOPROTEINS

• Relationship of lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in carotid atherosclerosis.
  (Vickers KC, et al. J Lipid Res. 2009 Apr 9. [Epub ahead of print])
  View Abstract
• Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.
  (Mahley RW, et al. J Lipid Res. 2009 Apr;50 Suppl:S183-8. Epub 2008 Dec 22.)
  View Abstract
• The role of dysfunctional HDL in atherosclerosis.
  (Navab M, et al. J Lipid Res. 2009 Apr;50 Suppl:S145-9. Epub 2008 Oct 27.)
  View Abstract

BIOMARKERS

• Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis.
  (Buhlin K, et al. Atherosclerosis. 2009 Apr 5. [Epub ahead of print])
  View Abstract
• Non-conventional markers of atherosclerosis before and after gastric banding surgery.
  (Hanusch-Enserer U, et al. Eur Heart J. 2009 Apr 20. [Epub ahead of print])
  View Abstract

DIABETES

• Diabetes and atherosclerosis: is there a role for hyperglycemia?
  (Chait A, et al. J Lipid Res. 2009 Apr;50 Suppl:S335-9. Epub 2008 Nov 23.)
  View Abstract
• Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities study.
  (Parker ED, et al. Am J Epidemiol. 2009 Apr 1;169(7):837-47. Epub 2009 Feb 18.)
  View Abstract
• Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis.
  (Rerkpattanapipat P, et al. Diabetes. 2009 Apr;58(4):946-53. Epub 2009 Jan 9.)
  View Abstract
• Association between circulating soluble receptor for advanced glycation end products (sRAGE) and atherosclerosis: Observations from the Dallas Heart Study.
  (Lindsey JB, et al. Diabetes Care. 2009 Apr 14. [Epub ahead of print])
  View Abstract

DIET, NUTRITION & METABOLISM

• Maternal undernutrition programmes atherosclerosis in the ApoE*3-Leiden mouse.
  (Yates Z, et al. Br J Nutr. 2009 Apr;101(8):1185-94. Epub 2008 Sep 10.)
  View Abstract
• Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Nettleton JA, et al. Diabetes Care. 2009 Apr;32(4):688-94. Epub 2009 Jan 16.)
  View Abstract
• Association of serum sodium concentration with coronary atherosclerosis in China: follow-up study.
  (Jia EZ, et al. Acta Pharmacol Sin. 2009 Apr;30(4):494-500. Epub 2009 Mar 23.)
  View Abstract
• Serum and dietary magnesium and risk of ischemic stroke: The Atherosclerosis Risk in Communities Study.
  (Ohira T, et al. Am J Epidemiol. 2009 Apr 16. [Epub ahead of print])
  View Abstract
• High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
  (Zulli A, et al. Hypertension. 2009 Jun;53(6):1017-22. Epub 2009 Apr 27.)
  View Abstract
• LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat.
  (Degirolamo C, et al. J Lipid Res. 2009 Apr;50 Suppl:S434-9. Epub 2008 Nov 22.)
  View Abstract

DRUG THERAPY

• Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.
  (Delaney JA, et al. Pharmacoepidemiol Drug Saf. 2009 Apr 28. [Epub ahead of print])
  View Abstract
• The monocyte/macrophage as a therapeutic target in atherosclerosis.
  (Saha P, et al. Curr Opin Pharmacol. 2009 Apr;9(2):109-18. Epub 2009 Feb 21.)
  View Abstract
• Macrophages: promising targets for the treatment of atherosclerosis.
  (Wilson HM, et al. Curr Vasc Pharmacol. 2009 Apr;7(2):234-43.)
  View Abstract
• Visceral adipose tissue and atherosclerosis.
  (Ohman MK, et al. Curr Vasc Pharmacol. 2009 Apr;7(2):169-79.)
  View Abstract
• Impact of ezetimibe on atherosclerosis: is the jury still out?
  (Al Badarin FJ, et al. Mayo Clin Proc. 2009 Apr;84(4):353-61. Review.)
  View Abstract
• Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
  (Fiévet C, et al. Biochem Pharmacol. 2009 Apr 15;77(8):1316-27. Epub 2008 Dec 3. Review.)
  View Abstract
• The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
  (van der Hoorn JW, et al. Br J Pharmacol. 2009 Apr;156(7):1067-75. Epub 2009 Feb 13.)
  View Abstract
• Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.
  (Baxter JD, et al. Nat Rev Drug Discov. 2009 Apr;8(4):308-20. Review.)
  View Abstract
• Eplerenone does not attenuate diabetes-associated atherosclerosis.
  (Koh PJ, et al. J Hypertens. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice.
  (Aoyama T, et al. Biochem Biophys Res Commun. 2009 May 29;383(2):216-21. Epub 2009 Apr 5.)
  View Abstract

GENETICS OF CVD

• THFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
  (Antoniades C, et al. Circulation. 2009 May 12;119(18):2507-15. Epub 2009 Apr 27.)
  View Abstract
• Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis.
  (Burillo E, et al. Atherosclerosis. 2009 Apr 16. [Epub ahead of print])
  View Abstract
• TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis.
  (Gong HP, et al. Diabetes Care. 2009 Apr 23. [Epub ahead of print])
  View Abstract
• Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.
  (Hulkkonen J, et al. Atherosclerosis. 2009 Apr;203(2):454-8. Epub 2008 Jul 25.)
  View Abstract
• SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
  (Volcik KA, et al. Clin Chem. 2009 Apr 24. [Epub ahead of print])
  View Abstract
• Smoking confers a MTHFR 677C>T genotype-dependent risk for systemic atherosclerosis: Results from a large number of elderly autopsy cases that died in a community-based general geriatric hospital.
  (Sawabe M, et al. J Atheroscler Thromb. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis.
  (Liu Y, et al. PLoS ONE. 2009;4(4):e5027. Epub 2009 Apr 3.)
  View Abstract
• Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.
  (Harja E, et al. FASEB J. 2009 Apr;23(4):1081-91. Epub 2008 Nov 26.)
  View Abstract

HYPERTENSION

• Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
  (David S, et al. J Hypertens. 2009 Apr 22. [Epub ahead of print])
  View Abstract

IMAGING

• Optical and multimodality molecular imaging. Insights into atherosclerosis.
  (Jaffer FA, et al. Arterioscler Thromb Vasc Biol. 2009 Apr 9. [Epub ahead of print])
  View Abstract
• Quantum dot mediated imaging of atherosclerosis.
  (Jayagopal A, et al. Nanotechnology. 2009 Apr 22;20(16):165102. Epub 2009 Mar 31.)
  View Abstract
• Magnetic resonance imaging and three-dimensional ultrasound of carotid atherosclerosis: mapping regional differences.
  (Krasinski A, et al. J Magn Reson Imaging. 2009 Apr;29(4):901-8.)
  View Abstract
• Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
  (Cormode DP, et al. Bioconjug Chem. 2009 Apr 20. [Epub ahead of print])
  View Abstract
• Albuminuria within the normal range and ultrasound-assessed atherosclerosis in the AIR study: a 9-year follow-up of 58-year-old clinically healthy men.
  (Herlitz H, et al. Scand J Clin Lab Invest. 2009 Apr 3:1-6. [Epub ahead of print])
  View Abstract

IMMUNOLOGY

• Prevention of atherosclerosis in patients living with HIV.
  (De Lorenzo F, et al. Vasc Health Risk Manag. 2009;5(1):287-300. Epub 2009 Apr 8.)
  View Abstract
• Connexins participate in the initiation and progression of atherosclerosis.
  (Morel S, et al. Semin Immunopathol. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.
  (Gautier EL, et al. Circulation. 2009 May 5;119(17):2367-75. Epub 2009 Apr 20.)
  View Abstract
• Cytokine network and T cell immunity in atherosclerosis.
  (Ait-Oufella H, et al. Semin Immunopathol. 2009 Apr 2. [Epub ahead of print])
  View Abstract
• The role of adaptive T cell immunity in atherosclerosis.
  (Mallat Z, et al. J Lipid Res. 2009 Apr;50 Suppl:S364-9. Epub 2008 Dec 2.)
  View Abstract
• Interferon gamma: a master regulator of atherosclerosis.
  (McLaren JE, et al. Cytokine Growth Factor Rev. 2009 Apr;20(2):125-35. Epub 2008 Nov 28.)
  View Abstract
• Emerging role of Toll-like receptors in atherosclerosis.
  (Curtiss LK, et al. J Lipid Res. 2009 Apr;50 Suppl:S340-5. Epub 2008 Nov 1.)
  View Abstract
• Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet.
  (Yearley JH, et al. Lab Invest. 2009 Apr 20. [Epub ahead of print])
  View Abstract

INNOVATIVE TECHNIQUES / MODELING

• Complex porcine model of atherosclerosis: induction of early coronary lesions after long-term hyperlipidemia without sustained hyperglycemia.
  (Artinger S, et al. Can J Cardiol. 2009 Apr;25(4):e109-14.)
  View Abstract

INFLAMMATION

• Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.
  (Arnaud C, et al. Semin Immunopathol. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• Obesity, inflammation, and atherosclerosis.
  (Rocha VZ, et al. Nat Rev Cardiol. 2009 Apr 28. [Epub ahead of print])
  View Abstract
• Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.
  (Ko KW, et al. Biochem Biophys Res Commun. 2009 Jun 19;384(1):93-9. Epub 2009 Apr 22.)
  View Abstract
• Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36.
  (Silverstein RL. Cleve Clin J Med. 2009 Apr;76 Suppl 2:S27-30.)
  View Abstract
• Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis.
  (Tavora F, et al. Cardiovasc Pathol. 2009 Apr 17. [Epub ahead of print])
  View Abstract
• Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis.
  (Armendariz AD, et al. Curr Opin Lipidol. 2009 Apr;20(2):106-11.)
  View Abstract
• Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
  (Bash LD, et al. Am J Kidney Dis. 2009 Apr;53(4):596-605. Epub 2008 Dec 24.)
  View Abstract
• Regulation of macrophage function in inflammation and atherosclerosis.
  (Shibata N, et al. J Lipid Res. 2009 Apr;50 Suppl:S277-81. Epub 2008 Nov 5.)
  View Abstract
• The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.
  (Montecucco F, et al. Mediators Inflamm. 2009;2009:752406. Epub 2009 Apr 14.)
  View Abstract
• Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).
  (Saremi A, et al. Atherosclerosis. 2009 Apr;203(2):610-4. Epub 2008 Aug 5.)
  View Abstract

MENOPAUSE

• Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women.
  (Seo SK, et al. Menopause. 2009 Apr 21. [Epub ahead of print])
  View Abstract

METABOLIC SYNDROME

• Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group.
  (Bang OY, et al. J Neurol Sci. 2009 Apr 25. [Epub ahead of print])
  View Abstract
• Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Katz R, et al. Diabetes. 2009 Apr;58(4):813-9. Epub 2009 Jan 9.)
  View Abstract
• Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond.
  (Pendse AA, et al. J Lipid Res. 2009 Apr;50 Suppl:S178-82. Epub 2008 Dec 5.)
  View Abstract

MISCELLANEOUS

• A historical perspective towards a non-invasive treatment for patients with atherosclerosis.
  (Slijkhuis W, et al. Neth Heart J. 2009 Apr;17(4):140-4.)
  View Abstract
• Chronic cor pulmonale secondary to pulmonary atherosclerosis in an African Grey parrot.
  (Sedacca CD, et al. J Am Vet Med Assoc. 2009 Apr 15;234(8):1055-9.)
  View Abstract
• Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events?
  (Sambuceti G, et al. J Nucl Cardiol. 2009 May-Jun;16(3):447-55. Epub 2009 Apr 22.)
  View Abstract

OBESITY

• The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.
  (Yan RT, et al. Atherosclerosis. 2009 Apr 16. [Epub ahead of print])
  View Abstract

OXIDATIVE STRESS

• Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
  (Liu SL, et al. Cardiovasc Res. 2009 Apr 1;82(1):161-9. Epub 2009 Feb 3.)
  View Abstract
• Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses Benzo(a)pyrene-accelerated atherosclerosis.
  (Yang H, et al. Atherosclerosis. 2009 Apr 11. [Epub ahead of print])
  View Abstract

PEDIATRICS

• Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
  (Solini A, et al. J Hum Hypertens. 2009 Apr 2. [Epub ahead of print])
  View Abstract
• Cardiovascular risk factors and atherosclerosis in young women: atherosclerosis risk factors in female youngsters (ARFY study).
  (Knoflach M, et al. Stroke. 2009 Apr;40(4):1063-9. Epub 2009 Feb 10.)
  View Abstract

RENAL DISEASE

• Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes.
  (Yamamoto R, et al. Diabetes Res Clin Pract. 2009 Apr;84(1):39-45. Epub 2009 Feb 14.)
  View Abstract

RISK FACTORS

• Is inflammatory bowel disease a risk factor for early atherosclerosis?
  (Dagli N, et al. Angiology. 2009 Apr 26. [Epub ahead of print])
  View Abstract
• Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
  (Zhang CY, et al. J Clin Rheumatol. 2009 Apr;15(3):111-6.)
  View Abstract
• Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the atherosclerosis risk in communities (ARIC) study.
  (Monda KL, et al. J Lipid Res. 2009 Apr 3. [Epub ahead of print])
  View Abstract
• Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study.
  (Nettleton JA, et al. Am J Epidemiol. 2009 Apr 16. [Epub ahead of print])
  View Abstract
• Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis.
  (Baldassarre D, et al. Stroke. 2009 Apr 9. [Epub ahead of print])
  View Abstract
• Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study.
  (Cheung N, et al. Psychosom Med. 2009 Apr;71(3):308-12. Epub 2008 Dec 10.)
  View Abstract
• Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease.
  (Gatto NM, et al. Int J Geriatr Psychiatry. 2009 Apr;24(4):390-9.)
  View Abstract
• The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study.
  (Rohatgi A, et al. Atherosclerosis. 2009 Apr;203(2):569-75. Epub 2008 Jul 25.)
  View Abstract
• C-reactive protein levels do not correlate with retinal artery occlusion but with atherosclerosis.
  (Goldenberg-Cohen N, et al. Eye. 2009 Apr;23(4):785-90. Epub 2008 Jun 6.)
  View Abstract
• The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.
  (Full LE, et al. Arthritis Res Ther. 2009 Apr 3;11(2):217. [Epub ahead of print])
  View Abstract
• A rare case of lack of correlation of carotid atherosclerosis and coronary atherosclerosis.
  (Dattilo G, et al. Int J Cardiol. 2009 Apr 2. [Epub ahead of print])
  View Abstract

STROKE

• Elevated levels of soluble P-selectin in mice alter blood brain barrier function, exacerbate stroke and promote atherosclerosis.
  (Kisucka J, et al. Blood. 2009 Apr 6. [Epub ahead of print])
  View Abstract
• Parity and carotid atherosclerosis in men and women: insights into the roles of childbearing and child-rearing.
  (Skilton MR, et al. Stroke. 2009 Apr;40(4):1152-7. Epub 2009 Feb 10.)
  View Abstract
• Association between wall shear stress and carotid atherosclerosis in patients with never treated essential hypertension.
  (Lee MY, et al. Am J Hypertens. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies.
  (Labreuche J, et al. Atherosclerosis. 2009 Apr;203(2):331-45. Epub 2008 Sep 10.)
  View Abstract
• Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
  (Huang YL, et al. Sci Total Environ. 2009 Apr 1;407(8):2608-14. Epub 2009 Feb 1.)
  View Abstract
• Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.
  (Soliman EZ, et al. Stroke. 2009 Apr;40(4):1204-11. Epub 2009 Feb 12.)
  View Abstract
• Pre-eclampsia is a risk factor of carotid artery atherosclerosis.
  (Haukkamaa L, et al. Cerebrovasc Dis. 2009 Apr 30;27(6):599-607. [Epub ahead of print])
  View Abstract
• Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
  (Li WF, et al. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):246-53. Epub 2009 Feb 5.)
  View Abstract
• Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis.
  (Succurro E, et al. Atherosclerosis. 2009 Apr 11. [Epub ahead of print])
  View Abstract
• Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis.
  (Bhavsar S, et al. Clin Invest Med. 2009 Apr 1;32(2):E95-102.)
  View Abstract

THROMBOSIS / HAEMOSTATIS

• Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis.
  (Libby P. J Lipid Res. 2009 Apr;50 Suppl:S352-7. Epub 2008 Dec 18.)
  View Abstract
• Atherosclerosis in thrombotic primary antiphospholipid syndrome.
  (Ames PR, et al. J Thromb Haemost. 2009 Apr;7(4):537-42. Epub 2009 Jan 19.)
  View Abstract

VASCULAR BIOLOGY

• Enhanced expression of vascular cell adhesion molecule-1 by corticotrophin-releasing hormone contributes to progression of atherosclerosis in LDL receptor-deficient mice.
  (Wu Y, et al. Atherosclerosis. 2009 Apr;203(2):360-70. Epub 2008 Jun 13.)
  View Abstract
• Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.
  (Yu Y, et al. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7985-90. Epub 2009 Apr 24.)
  View Abstract
• Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis.
  (Wang H, et al. Arterioscler Thromb Vasc Biol. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis.
  (Zhu L, et al. Arterioscler Thromb Vasc Biol. 2009 Apr 23. [Epub ahead of print])
  View Abstract
• Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis.
  (Swirski FK, et al. Arterioscler Thromb Vasc Biol. 2009 Apr 16. [Epub ahead of print])
  View Abstract
• Myocardial bridges spared from atherosclerosis: overview of the underlying mechanisms.
  (Chatzizisis YS, et al. Can J Cardiol. 2009 Apr;25(4):219-22.)
  View Abstract
• Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
  (Brunham LR, et al. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):548-54. Epub 2009 Feb 5.)
  View Abstract
• Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
  (Ortiz-Muñoz G, et al. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):525-31. Epub 2009 Jan 22.)
  View Abstract
• ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
  (Parks BW, et al. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):539-47. Epub 2009 Jan 22.)
  View Abstract
• Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
  (Hlawaty H, et al. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):518-24. Epub 2009 Jan 22.)
  View Abstract
• Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword?
  (Liu P, et al. Ageing Res Rev. 2009 Apr;8(2):83-93. Epub 2008 Dec 3.)
  View Abstract
• The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.
  (Rader DJ, et al. J Lipid Res. 2009 Apr;50 Suppl:S189-94. Epub 2008 Dec 8.)
  View Abstract
• The role of oxidized phospholipids in atherosclerosis.
  (Berliner JA, et al. J Lipid Res. 2009 Apr;50 Suppl:S207-12. Epub 2008 Dec 4.)
  View Abstract
• Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
  (Seimon T, et al. J Lipid Res. 2009 Apr;50 Suppl:S382-7. Epub 2008 Oct 25.)
  View Abstract
• Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
  (Matthijsen RA, et al. Circulation. 2009 Apr 28;119(16):2188-95. Epub 2009 Apr 20.)
  View Abstract
• Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
  (Guo T, et al. Atherosclerosis. 2009 Apr 17. [Epub ahead of print])
  View Abstract